Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Botvik Biotechnology is a specialized life sciences company headquartered in Beijing, China, that focuses on the development and production of high-performance molecular biology reagents. Founded in 2015, the company has established itself as a key provider of solutions for next-generation sequencing (NGS) library preparation and nucleic acid extraction. Their core product line, marketed under the BotPrep brand, includes automated workstations and kits designed to streamline genomic workflows for clinical diagnostics and research. Botvik's technologies are primarily applied in oncology, genetic testing, and infectious disease monitoring to support precision medicine initiatives. The company serves a broad range of clients, including top-tier hospitals, research institutes, and commercial diagnostic laboratories across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Botvik Biotechnology.